Paul Talmo Biography and Net Worth

CTO of TELA Bio

Paul Talmo possesses over 20 years of experience commercializing technologies within the medical device and service industries including medical devices, implantable materials, as well as imaging and diagnostic technologies and services. Mr. Talmo spent 16 years at LifeCell Corporation and was an impetus behind the transformation of a burn-focused company into a soft tissue reconstruction company. Mr. Talmo was responsible for first introducing biologic materials to the urogynecology market, for urinary incontinence and pelvic floor reconstruction, as well as the general surgery market, for hernia repair.

Mr. Talmo also worked closely with surgeons to develop the various techniques and protocols for implant-based reconstruction with the first biologic material used in breast reconstruction, eventually commercializing the material and new techniques in the early 2000s. Mr. Talmo applies his years of clinical and commercial experience with innovative and strategic thinking to create unique disruptive business models.

What is Paul Talmo's net worth?: The estimated net worth of Paul Talmo is at least $123.87 thousand as of October 24th, 2024. Mr. Talmo owns 91,082 shares of TELA Bio stock worth more than $123,872 as of September 22nd. This net worth approximation does not reflect any other investments that Mr. Talmo may own. Learn More about Paul Talmo's net worth.
How do I contact Paul Talmo?: The corporate mailing address for Mr. Talmo and other TELA Bio executives is 1 GREAT VALLEY PARKWAY SUITE 24, MALVERN PA, 19355. TELA Bio can also be reached via phone at 484-320-2930 and via email at [email protected]. Learn More on Paul Talmo's contact information.
Has Paul Talmo been buying or selling shares of TELA Bio?: Paul Talmo has not been actively trading shares of TELA Bio in the last ninety days. Most recently, on Thursday, October 24th, Paul Talmo bought 22,222 shares of TELA Bio stock. The stock was acquired at an average cost of $2.25 per share, with a total value of $49,999.50. Following the completion of the transaction, the chief technology officer now directly owns 91,082 shares of the company's stock, valued at $204,934.50. Learn More on Paul Talmo's trading history.
Who are TELA Bio's active insiders?: TELA Bio's insider roster includes Joseph Capper (Director), Roberto Cuca (CFO), and Paul Talmo (CTO). Learn More on TELA Bio's active insiders.
Are insiders buying or selling shares of TELA Bio?: During the last year, TELA Bio insiders bought shares 5 times. They purchased a total of 3,719,000 shares worth more than $4,119,940.00. The most recent insider tranaction occured on September, 17th when Director Joseph H. Capper bought 25,000 shares worth more than $30,500.00. Insiders at TELA Bio own 1.1% of the company. Learn More about insider trades at TELA Bio.
Information on this page was last updated on 9/17/2026.

Paul Talmo Insider Trading History at TELA Bio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
10/24/2024	Buy	22,222	$2.25	$49,999.50	91,082

Paul Talmo Buying and Selling Activity at TELA Bio

TELA Bio Company Overview

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Today's Range

Now: $1.40

$1.28

$1.42

50 Day Range

MA: $0.80

$0.64

$1.30

2 Week Range

Now: $1.40

$0.50

$1.66

Volume

190,139 shs

Average Volume

186,981 shs

Market Capitalization

$63.02 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.36